Table 3

Prevalence of MetS components according to the Interim consensus (IDF-C) or the modified NCEP ATP III (ATP III-M) criteria
IDF-Ca [n(%)] ATP III-Mb [n(%)]
No. of Criteria met DM and CHD included DM and CHD excluded DM and CHD included DM and CHD excluded
Met 5 criteria 686(3.1) 382(2.0) 198(0.9) 77(0.4)
Met 4 criteria 2318(10.3) 1667(8.6) 1328(5.9) 797(4.1)
Met 3 criteria 4518(20.1) 3497(18.1) 3824(17.0) 2761(14.3)
Met 2 criteria 5776(25.7) 5014(26.0) 5953(26.5) 5059(26.2)
Met 1 criteria 5386(24.0) 5026(26.1) 6502(29.0) 6031(31.3)
Met 0 criteria 3773(16.8) 3698(19.2) 4652(20.7) 4559(23.7)
total 22457 19284 22457 19284

aIDF-C (joint interim consensus criteria by IDF and other organization): Diabetes or fasting glucose ≥ 100 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥ 85 mmHg; Dyslipidemia or HDL < 40 mg/dL for men and HDL < 50 mg/dL for women; Dyslipidemia or Triglycerides ≥ 150 mg/dL; Waist circumference ≥ 85 cm for men and ≥ 80 cm for women.

bATP III-M (modified NCEP ATP III criteria): Diabetes or fasting glucose ≥ 110 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥ 85mmHg; Dyslipidemia or HDL < 40 mg/dL for both men and women; Dyslipidemia or Triglycerides ≥ 150 mg/dL; Waist circumference ≥ 90cm for men and ≥ 80 cm for women.

Wang et al.

Wang et al. BMC Public Health 2013 13:599   doi:10.1186/1471-2458-13-599

Open Data